公开(公告)号：EP3835413A1

公开(公告)日：2021-06-16

申请号：EP19848242.4

申请日：2019-08-09

申请人： Zhejiang Hygeiancells Biomedical Co. Ltd

发明人： QIAN, Jin ,  XU, Jiayi ,  WANG, Jimin

IPC分类号： C12N5/00

摘要： A method and composition for promoting cell growth and tissue repair, relating a use of amniotic fluid from non-human animals, especially birds and non-human mammals, and/or an extract thereof. The composition may be a cell culture medium containing the amniotic fluid and/or the extract thereof, or may be a pharmaceutical composition.

公开(公告)号：EP3834834A1

公开(公告)日：2021-06-16

申请号：EP19847075.9

申请日：2019-08-09

申请人： Zhejiang Hygeiancells Biomedical Co. Ltd

发明人： QIAN, Jin ,  SUN, Ning ,  GAO, Xiang ,  CUI, Baiping ,  ZHENG, Yufan

IPC分类号： A61K35/57 ,  A61K9/19 ,  A61K9/10 ,  A61P9/10

摘要： A drug used for treating ischemia and hypoxia-induced tissue necrosis or for improving cardiac function; the drug contains amniotic fluid from a non-human animal and/or an extract thereof, and an optional pharmaceutically acceptable carrier, wherein the amniotic fluid comes from chicken eggs having an embryonic age of 5-12 days, eggs from other birds corresponding to the described developmental period, embryos from rodents having a gestational age of 8-20 days, or embryos from other non-human mammals corresponding to the described developmental period. The drug may promote the growth of human umbilical vein endothelial cells, AC16 cells and chicken embryo fibroblasts, improve cardiac function after myocardial infarction, and promote cardiac cell regeneration after a myocardial infarction.